February 16, 2017 / 7:08 AM / in 8 months

BRIEF-Rovi FY net profit up 32 pct YoY

Feb 16 (Reuters) - Laboratorios Farmaceuticos Rovi :

* FY net profit 26.1 million euros ($27.7 million) versus 19.8 million euros year ago

* The increase in net profit is mainly due to the positive impact of non-recurring income of 4 million euros registered as a result of the creation of a joint venture by ROVI and Enervit

* FY operating revenue 265.2 million euros versus 246.0 million euros year ago

* FY EBITDA 39.3 million euros versus 31.8 million euros year ago

* To propose dividend for 2016 of 0.1830 euro per share Source text: bit.ly/2kVcASR bit.ly/2kMwf50

Further company coverage: ($1 = 0.9427 euros) (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below